HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana
Author(s) -
Ontlametse T. Bareng,
Sikhulile Moyo,
Melissa Zahralban-Steele,
Dorcas Maruapula,
Tsotlhe R. Ditlhako,
Baitshepi Mokaleng,
Patrick Mokgethi,
Wonderful T. Choga,
Natasha O. Moraka,
Molly Pretorius-Holme,
Madisa Mine,
Elliot Raizes,
Kesaobaka Molebatsi,
Modisa S. Motswaledi,
Irene Gobe,
Terence Mohammed,
Tendani Gaolathe,
Roger Shapiro,
Mompati Mmalane,
Joseph Makhema,
Shahin Lockman,
Max Essex,
Vlad Novitsky,
Simani Gaseitsiwe,
Helen Ayles,
Lucie AbelerDörner,
David Bonsall,
Rory Bowden,
Sarah Fidler,
Christophe Fraser,
Kate Grabowski,
Tanya Golubchik,
Ravindra K. Gupta,
Richard Hayes,
Joshua T. Herbeck,
Joseph Kagaayi,
Pontiano Kaleebu,
Jairam R. Lingappa,
Vladimir Novitsky,
Deenan Pillay,
Thomas C. Quinn,
Andrew Rambaut,
Oliver Ratmann,
Janet Seeley,
Deogratius Ssemwanga,
Frank Tanser,
Maria J. Wawer
Publication year - 2022
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkac056
Subject(s) - drug resistance , human immunodeficiency virus (hiv) , medicine , virology , antiretroviral therapy , viral load , immunology , biology , genetics
To assess whether a single instance of low-level viraemia (LLV) is associated with the presence of drug resistance mutations (DRMs) and predicts subsequent virological failure (VF) in adults receiving ART in 30 communities participating in the Botswana Combination Prevention Project.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom